Literature DB >> 22768838

Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.

Kento Imajo1, Koji Fujita, Masato Yoneda, Yuichi Nozaki, Yuji Ogawa, Yoshiyasu Shinohara, Shingo Kato, Hironori Mawatari, Wataru Shibata, Hiroshi Kitani, Kenichi Ikejima, Hiroyuki Kirikoshi, Noriko Nakajima, Satoru Saito, Shiro Maeyama, Sumio Watanabe, Koichiro Wada, Atsushi Nakajima.   

Abstract

Although bacterial endotoxin, such as lipopolysaccharide (LPS), plays a key role in the pathogenesis of nonalcoholic steatohepatitis (NASH), detailed mechanisms of this pathogenesis remain unclear. Here, we demonstrate that upregulation of CD14 by leptin-mediated signaling is critical to hyperreactivity against endotoxin during NASH progression. Upregulation of CD14 in Kupffer cells and hyperreactivity against low-dose LPS were observed in high-fat diet (HFD)-induced steatosis mice, but not chow-fed-control mice. Hyperresponsivity against low-dose LPS led to accelerated NASH progression, including liver inflammation and fibrosis. Administering leptin in chow-fed mice caused increased hepatic expression of CD14 via STAT3 signaling, resulting in hyperreactivity against low-dose LPS without steatosis. In contrast, a marked decrease in hepatic CD14 expression was observed in leptin-deficient ob/ob mice, despite severe steatosis. Our results indicate that obesity-induced leptin plays a crucial role in NASH progression via enhanced responsivity to endotoxin, and we propose a mechanism of bacteria-mediated progression of NASH.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22768838     DOI: 10.1016/j.cmet.2012.05.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  139 in total

Review 1.  Gut microbiota and liver diseases.

Authors:  Masami Minemura; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 2.  The Influence of the Microbiome on NAFLD and NASH.

Authors:  Somaya A M Albhaisi; Jasmohan S Bajaj
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

3.  Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.

Authors:  Takashi Shida; Kentaro Akiyama; Sechang Oh; Akemi Sawai; Tomonori Isobe; Yoshikazu Okamoto; Kazunori Ishige; Yuji Mizokami; Kenji Yamagata; Kojiro Onizawa; Hironori Tanaka; Hiroko Iijima; Junichi Shoda
Journal:  J Gastroenterol       Date:  2017-08-08       Impact factor: 7.527

Review 4.  Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.

Authors:  Veerle Bieghs; Christian Trautwein
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

5.  The liver diseases of lipodystrophy: the long-term effect of leptin treatment.

Authors:  Elika Safar Zadeh; Andreea O Lungu; Elaine K Cochran; Rebecca J Brown; Marc G Ghany; Theo Heller; David E Kleiner; Phillip Gorden
Journal:  J Hepatol       Date:  2013-02-21       Impact factor: 25.083

Review 6.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

7.  Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis.

Authors:  Noha F Hassan; Somaia A Nada; Azza Hassan; Mona R El-Ansary; Muhammad Y Al-Shorbagy; Rania M Abdelsalam
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 8.  Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.

Authors:  Kouichi Miura; Hirohide Ohnishi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

Authors:  Khalidur Rahman; Chirayu Desai; Smita S Iyer; Natalie E Thorn; Pradeep Kumar; Yunshan Liu; Tekla Smith; Andrew S Neish; Hongliang Li; Shiyun Tan; Pengbo Wu; Xiaoxiong Liu; Yuanjie Yu; Alton B Farris; Asma Nusrat; Charles A Parkos; Frank A Anania
Journal:  Gastroenterology       Date:  2016-06-21       Impact factor: 22.682

Review 10.  Microbiota-liver axis in hepatic disease.

Authors:  Benoit Chassaing; Lucie Etienne-Mesmin; Andrew T Gewirtz
Journal:  Hepatology       Date:  2013-11-15       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.